Additional file 1: of Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Name: Additional file 1: of Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Creator: Zhichao Liu; Leihong Wu; Junshuang Yang; Weida Tong; Guangxu Zhou; Weigong Ge
Published: 2019-03-15T00:00:00+08:00

Figshare2019-03-15 更新2026-04-08 收录

药物不良反应监测

MedDRA术语应用

数据链接：

https://springernature.figshare.com/articles/Additional_file_1_of_Study_of_serious_adverse_drug_reactions_using_FDA-approved_drug_labeling_and_MedDRA/7850456/1 数据链接链接失效反馈

官方服务：

资源简介：

Table S1. The entire MedDRA PT corpus for Boxed Warning sections among selected 367 drugs; (XLS 62 kb)

提供机构：

Zhichao Liu; Leihong Wu; Junshuang Yang; Weida Tong; Guangxu Zhou; Weigong Ge

创建时间：

2019-03-15

Additional file 1: of Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

资源简介：

相关数据集